Compile Data Set for Download or QSAR
Report error Found 162 of affinity data for UniProtKB/TrEMBL: Q7Z6P4
TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617543BDBM617543(US20230286943, Example 11)
Affinity DataIC50: 20nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617633BDBM617633(US20230286943, Example 101)
Affinity DataIC50: 31.6nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617538BDBM617538(US20230286943, Example 6)
Affinity DataIC50: 31.6nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617626BDBM617626(US20230286943, Example 94)
Affinity DataIC50: 31.6nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617671BDBM617671(US20230286943, Example 139)
Affinity DataIC50: 31.6nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617578BDBM617578(US20230286943, Example 46)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617642BDBM617642(US20230286943, Example 110)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617627BDBM617627(US20230286943, Example 95)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617573BDBM617573(US20230286943, Example 41)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617574BDBM617574(US20230286943, Example 42)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617575BDBM617575(US20230286943, Example 43)
Affinity DataIC50: 39.8nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617544BDBM617544(US20230286943, Example 12)
Affinity DataIC50: 50.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617577BDBM617577(US20230286943, Example 45)
Affinity DataIC50: 50.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617547BDBM617547(US20230286943, Example 15)
Affinity DataIC50: 50.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617587BDBM617587(US20230286943, Example 55)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617661BDBM617661(US20230286943, Example 129)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617534BDBM617534(US20230286943, Example 2)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617582BDBM617582(US20230286943, Example 50)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617614BDBM617614(US20230286943, Example 82)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617535BDBM617535(US20230286943, Example 3)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617567BDBM617567(US20230286943, Example 35)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617615BDBM617615(US20230286943, Example 83)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617659BDBM617659(US20230286943, Example 127)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617541BDBM617541(US20230286943, Example 9)
Affinity DataIC50: 63.1nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617600BDBM617600(US20230286943, Example 68)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617555BDBM617555(US20230286943, Example 23)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617548BDBM617548(US20230286943, Example 16)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617533BDBM617533(US20230286943, Example 1)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617629BDBM617629(US20230286943, Example 97)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617583BDBM617583(US20230286943, Example 51)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617561BDBM617561(US20230286943, Example 29)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617562BDBM617562(US20230286943, Example 30)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617652BDBM617652(US20230286943, Example 120)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617654BDBM617654(US20230286943, Example 122)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617622BDBM617622(US20230286943, Example 90)
Affinity DataIC50: 79.4nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617664BDBM617664(US20230286943, Example 132)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617650BDBM617650(US20230286943, Example 118)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617663BDBM617663(US20230286943, Example 131)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617560BDBM617560(US20230286943, Example 28)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617546BDBM617546(US20230286943, Example 14)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617610BDBM617610(US20230286943, Example 78)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617563BDBM617563(US20230286943, Example 31)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617620BDBM617620(US20230286943, Example 88)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617557BDBM617557(US20230286943, Example 25)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617606BDBM617606(US20230286943, Example 74)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617639BDBM617639(US20230286943, Example 107)
Affinity DataIC50: 100nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617666BDBM617666(US20230286943, Example 134)
Affinity DataIC50: 126nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617554BDBM617554(US20230286943, Example 22)
Affinity DataIC50: 126nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617566BDBM617566(US20230286943, Example 34)
Affinity DataIC50: 126nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetInterleukin-17F(Human)
Sanofi

US Patent
LigandChemical structure of BindingDB Monomer ID 617657BDBM617657(US20230286943, Example 125)
Affinity DataIC50: 126nMAssay Description:The ability of the compounds to block binding of IL-17A to its receptor, IL-17RA, was analysed in a competition assay using AlphaLISA technology (Per...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: